Motley Fool1d agobullish
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Motley Fool2d agobullish
3 High-Yield Healthcare Stocks to Buy With $1,000 and Hold Through Any MarketSimply Wall St.3d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Rally Already Priced In?Motley Fool6d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?Simply Wall St.8d agobullish
What Bristol Myers Squibb Stock's Earnings Beat Means For ShareholdersPharmaceutical Technology9d agobullish
Eli Lilly’s tirzepatide outperforms big pharma companies in Q324/7 Wall St.38d agobullish
5 High-Yield Dividends With Ex-Dates Days Away: Buy Before the Window ClosesMotley Fool40d agobullish
Bristol Myers Squibb vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool42d agobullish
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool45d agobullish
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool51d agobullish
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool56d agobullish
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?Insider Monkey60d agobullish
Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?BioPharma Dive61d agobullish
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy24/7 Wall St.62d agobullish
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now